Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 4.761

Combinatorial nanomedicines for colon cancer therapy

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Colon cancer is one of the major causes of cancer deaths worldwide. Even after surgical resection and aggressive chemotherapy, 50% of colorectal carcinoma patients develop recurrent disease. Thus, the rationale of developing new therapeutic approaches to improve the current chemotherapeutic regimen would be highly recommended. There are reports on the effectiveness of combination chemotherapy in colon cancer and it has been practiced in clinics for long time. These approaches are associated with toxic side effects. Later, the drug delivery research had shown the potential of nanoencapsulation techniques and active targeting as an effective method to improve the effectiveness of chemotherapy with less toxicity. This current focus article provides a brief analysis of the ongoing research in the colon cancer area using the combinatorial nanomedicines and its outcome. WIREs Nanomed Nanobiotechnol 2015, 8:151–159. doi: 10.1002/wnan.1353

(a) Depict the staging of colon cancer, and (b) depicts the presence of colon polyps and cancerous areas in the different regions of colon. (Source: http://www.medicinenet.com/colon_cancer/article.htm)
[ Normal View | Magnified View ]
The mechanistic pathway through which CRC sensitizes HT‐29 to 5‐FU and the combinatorial effect of dual drug‐loaded nanoparticles. (Reprinted with permission from Ref . Copyright 2015 Elsevier)
[ Normal View | Magnified View ]
Z stacked images of HT‐29 cells treated with Rhod 123‐CRC‐N, O‐CMC NPs for 6 h using Confocal Laser Scanning Microscopy (CLSM), where the merged views of fluorescence from the tetramethylrhodamine (TRITC)‐stained actin filaments/Rhod 123‐CRC‐N, O‐CMC NPs were measured. Nine confocal sections from the basal to the apical cell side (Z1–Z9 planes) are depicted as (a), (b), (c), (d), (e), (f), (g), (h), and (i), respectively (scale bar represents 50 µm) (Done in triplicates; n = 3, and each experiment was repeated thrice). (Unpublished data, A. Anitha)
[ Normal View | Magnified View ]
Scheme representing the effect of combinatorial treatment of CRC‐loaded thiolated chitosan nanoparticles (CRC‐TCS NPs) and 5‐FU‐loaded thiolated chitosan nanoparticles (5‐FU‐TCS NPs) in colon cancer (HT‐29) cells. (Reprinted with permission from Ref . Copyright 2015 Elsevier)
[ Normal View | Magnified View ]
The flow chart depicting the advantages of combinatorial nanomedicines in colon cancer treatment.
[ Normal View | Magnified View ]

Related Articles

Nanotechnology and Cancer
Top Ten WNAN Articles

Browse by Topic

Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Therapeutic Approaches and Drug Discovery > Oncologic Disease

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts

In the Spotlight

Mauro Ferrari

Mauro Ferrari

started out in mechanical engineering and became interested in nanotechnology with his studies on nanomechanics and nanofluidics. His research work and involvement with setting up some of the premier nano centers and alliances in the world, bringing together universities, hospitals, and federal agencies, showcases interdisciplinarity at work.

Learn More